Nigel Mouncey

Nigel Mouncey


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2020 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
SNStephen Nayfach
Stephen Nayfach
SRSimon Roux
Simon Roux
RSRekha Seshadri
Rekha Seshadri
DUDaniel Udwary
Daniel Udwary
NVNeha Varghese
Neha Varghese
EEEmiley A. Eloe-Fadrosh
Emiley A. Eloe-Fadrosh
The reconstruction of bacterial and archaeal genomes from shotgun metagenomes has enabled insights into the ecology and evolution of environmental and host-associated microbiomes. Here we applied this approach to >10,000 metagenomes collected from diverse habitats covering all of Earth’s continents and oceans, including metagenomes from human and animal hosts, engineered environments, and natural and agricultural soils, to capture extant microbial, metabolic and functional potential. This comprehensive catalog includes 52,515 metagenome-assembled genomes representing 12,556 novel candidate species-level operational taxonomic units spanning 135 phyla. The catalog expands the known phylogenetic diversity of bacteria and archaea by 44% and is broadly available for streamlined comparative analyses, interactive exploration, metabolic modeling and bulk download. We demonstrate the utility of this collection for understanding secondary-metabolite biosynthetic potential and for resolving thousands of new host linkages to uncultivated viruses. This resource underscores the value of genome-centric approaches for revealing genomic properties of uncultivated microorganisms that affect ecosystem processes.

14 October 2019 in Nature Microbiology
Verified
Journal Article
Closed access
GWGaoyan Wang
Gaoyan Wang
ZZZhiying Zhao
Zhiying Zhao
JKJing Ke
Jing Ke
YEYvonne Engel
Yvonne Engel
YSYi-Ming Shi
Yi-Ming Shi
Yasuo YoshikuniYasuo Yoshikuni
Yasuo Yoshikuni

24 June 2022 in Science
Verified
Journal Article
Closed access
JVJean-Marie Volland
Jean-Marie Volland
SGSilvina Gonzalez-Rizzo
Silvina Gonzalez-Rizzo
OGOlivier Gros
Olivier Gros
TTTomáš Tyml
Tomáš Tyml
NINatalia Ivanova
Natalia Ivanova
SDShailesh V. Date
Shailesh V. Date
Cells of most bacterial species are around 2 micrometers in length, with some of the largest specimens reaching 750 micrometers. Using fluorescence, x-ray, and electron microscopy in conjunction with genome sequencing, we characterized Candidatus ( Ca. ) Thiomargarita magnifica, a bacterium that has an average cell length greater than 9000 micrometers and is visible to the naked eye. These cells grow orders of magnitude over theoretical limits for bacterial cell size, display unprecedented polyploidy of more than half a million copies of a very large genome, and undergo a dimorphic life cycle with asymmetric segregation of chromosomes into daughter cells. These features, along with compartmentalization of genomic material and ribosomes in translationally active organelles bound by bioenergetic membranes, indicate gain of complexity in the Thiomargarita lineage and challenge traditional concepts of bacterial cells.

17 January 2025 in Nature Reviews Microbiology
Verified
Journal Article
Closed access
PDF file
JDJaime Lorenzo N. Dinglasan
Jaime Lorenzo N. Dinglasan
HOHiroshi Otani
Hiroshi Otani
DDDrew T. Doering
Drew T. Doering
DUDaniel Udwary
Daniel Udwary
NMNigel Mouncey
Nigel Mouncey

7 November 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HOHiroshi Otani
Hiroshi Otani
DUDaniel W. Udwary
Daniel W. Udwary
NMNigel Mouncey
Nigel Mouncey
Streptomycetes are highly metabolically gifted bacteria with the abilities to produce bioproducts that have profound economic and societal importance. These bioproducts are produced by metabolic pathways including those for the biosynthesis of secondary metabolites and catabolism of plant biomass constituents. Advancements in genome sequencing technologies have revealed a wealth of untapped metabolic potential from Streptomyces genomes. Here, we report the largest Streptomyces pangenome generated by using 205 complete genomes. Metabolic potentials of the pangenome and individual genomes were analyzed, revealing degrees of conservation of individual metabolic pathways and strains potentially suitable for metabolic engineering. Of them, Streptomyces bingchenggensis was identified as a potent degrader of plant biomass. Polyketide, non-ribosomal peptide, and gamma-butyrolactone biosynthetic enzymes are primarily strain specific while ectoine and some terpene biosynthetic pathways are highly conserved. A large number of transcription factors associated with secondary metabolism are strain-specific while those controlling basic biological processes are highly conserved. Although the majority of genes involved in morphological development are highly conserved, there are strain-specific varieties which may contribute to fine tuning the timing of cellular differentiation. Overall, these results provide insights into the metabolic potential, regulation and physiology of streptomycetes, which will facilitate further exploitation of these important bacteria.

19 March 2025 in Chemical Society Reviews
Verified
Journal Article
Open access
PDF file
ARAndrew J. Rice
Andrew J. Rice
TSTien T. Sword
Tien T. Sword
KCKameshwari Chengan
Kameshwari Chengan
DMDouglas A. Mitchell
Douglas A. Mitchell
NMNigel Mouncey
Nigel Mouncey
CBConstance Bailey
Constance Bailey
Natural products have applications as biopharmaceuticals, agrochemicals, and other high-value chemicals. However, there are challenges in isolating natural products from their native producers (e.g. bacteria, fungi, plants). In many cases, synthetic chemistry or heterologous expression must be used to access these important molecules. The biosynthetic machinery to generate these compounds is found within biosynthetic gene clusters, primarily consisting of the enzymes that biosynthesise a range of natural product classes (including, but not limited to ribosomal and nonribosomal peptides, polyketides, and terpenoids). Cell-free synthetic biology has emerged in recent years as a bottom-up technology applied towards both prototyping pathways and producing molecules. Recently, it has been applied to natural products, both to characterise biosynthetic pathways and produce new metabolites. This review discusses the core biochemistry of cell-free synthetic biology applied to metabolite production and critiques its advantages and disadvantages compared to whole cell and/or chemical production routes. Specifically, we review the advances in cell-free biosynthesis of ribosomal peptides, analyse the rapid prototyping of natural product biosynthetic enzymes and pathways, highlight advances in novel antimicrobial discovery, and discuss the rising use of cell-free technologies in industrial biotechnology and synthetic biology.